Literature DB >> 3124937

Postoophorectomy bone loss is associated with reduced bone Gla protein serum levels: a possible effect of osteoblastic insufficiency.

C E Fiore1, E Falcidia, R Foti, S Caschetto, D R Grimaldi.   

Abstract

To further investigate the relationship between oophorectomy (OF) and mineral bone loss, 15 women who underwent total hysterectomy and bilateral oophorectomy were studied for 12 months after surgery. Mineralometric and metabolic data were obtained before and after 3, 6, and 12 months. The women lost bone mineral content (measured by single photon absorptiometry) at the same rate they lost cortical and trabecular bone, suggesting that bone loss after OF is a generalized phenomenon. Our data also show that an increase in bone resorption takes place only in the first period after OF; the persistency of a negative bone balance up to 12 months, accompanied by a reduction of osteocalcin serum levels, may be dependent on a reduced bone formation, probably due to osteoblastic insufficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124937     DOI: 10.1007/bf02556666

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  22 in total

1.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone.

Authors:  P A Price; A A Otsuka; J W Poser; J Kristaponis; N Raman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  Proof that the gamma-carboxyglutamic acid-containing bone protein is synthesized in calf bone. Comparative synthesis rate and effect of coumadin on synthesis.

Authors:  S K Nishimoto; P A Price
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

Review 3.  The hormonal and local regulation of bone formation.

Authors:  E Canalis
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

4.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

5.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

6.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting.

Authors:  D M Slovik; C M Gundberg; R M Neer; J B Lian
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

7.  Inflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass.

Authors:  H W Minne; J Pfeilschifter; S Scharla; S Mutschelknauss; A Schwarz; B Krempien; R Ziegler
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

8.  [Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology].

Authors:  P D Delmas; B Demiaux; L Malaval; M C Chapuy; P J Meunier
Journal:  Presse Med       Date:  1986-04-05       Impact factor: 1.228

9.  Low serum osteocalcin levels in glucocorticoid-treated asthmatics.

Authors:  I R Reid; G E Chapman; T R Fraser; A D Davies; A S Surus; J Meyer; N L Huq; H K Ibbertson
Journal:  J Clin Endocrinol Metab       Date:  1986-02       Impact factor: 5.958

10.  Changes in plasma bone GLA protein during treatment of bone disease.

Authors:  L J Deftos; J G Parthemore; P A Price
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

View more
  1 in total

1.  Sex differences in bone resorption in the mouse femur. A light- and scanning electron-microscopic study.

Authors:  K Abe; Y Aoki
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.